Tuesday, January 8, 2008

Epocrates Gets Investment By Goldman Sachs

San Mateo-based Epocrates, a company developing clinical information and decision support tools for the healthcare industry, said Monday that it has received a round of funding from Goldman Sachs. Epocrates said the strategic investment int he company also included an agreement to co-market the firm's market research services. Financial terms of the investment were not disclosed. Epocrates develops software used for drug, disease and diagnostic decision support. Hudson Street, which is owned by Goldman Sachs, will co-market Epocrates' market research to institutional clients in the financial sector, the firm said. More information »